Research conducted at the Lady Davis Institute provides proof of concept that an existing drug holds promise for reversing loss of memory and brain lesions associated with Alzheimer disease.
New research conducted at the Lady Davis Institute (LDI) at the Jewish General Hospital reveals that a novel drug reverses memory deficits and stops Alzheimer disease pathology (AD) in an animal model. Importantly, this drug has already proven to be non-toxic for humans in a clinical setting and could, therefore, be brought quickly to trials in humans against AD. These findings are published today in Nature Communications.
For years, Dr. Andréa LeBlanc, Senior Investigator at the LDI and Professor of Neurology and Neurosurgery at McGill University, has strived to identify early neurodegenerative events responsible for age-related memory loss. Her team discovered that the Caspase-6 enzyme is highly activated in Alzheimer disease brain lesions and associated with loss of memory. She, therefore, pursued the hypothesis that stopping Caspase-6 might provide relief from memory loss and stop progressive dementia. Since there are no specific Caspase-6 inhibitors, the LeBlanc team moved upstream, ultimately discovering that Caspase-1 was responsible for activating Caspase-6.
“This was a significant revelation because Caspase-1 inhibitors had been developed for treating inflammatory diseases,” explains Dr. LeBlanc. “Thus, we decided to test the effects of a particular Caspase-1 inhibitor, called VX-765, against memory loss and brain pathologies in a mouse model of Alzheimer disease.”
The work, first authored by Dr. Joseph Flores, a research associate in the LeBlanc lab, showed that VX-765 has an unprecedented beneficial effect in Alzheimer mice. The drug rapidly reverses memory loss, eliminates inflammation, and stops Alzheimer’s prototypical amyloid peptide accumulation in the mice brains. In addition to being safe for humans at relatively high doses for extended periods of time, it is capable of reaching the brain, a significant challenge in the development of drugs against disorders of the brain.
While Dr. LeBlanc cautions that there is a considerable bridge to cross between the mouse brain and that of a human, she believes that since her work has first identified the Caspase-1/Caspase-6 neurodegenerative pathway in human neurons and in human Alzheimer brains, there is a chance that this drug will work just as well in humans as it did in mice. Nevertheless, a clinical trial is needed to determine whether the drug will be beneficial against Alzheimer disease in humans.
Presently, there are no efficient treatments to significantly treat Alzheimer disease, the major affliction in a group of dementias that affect 47.5 million individuals worldwide.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
Breaking open the stigma of Alzheimers, local support group helps caregivers
on January 18, 2019 at 3:06 pm
Suzanne Allan describes Alzheimer’s as a journey. It’s one she’s watched her mother take. And now her father is progressing down the same path. Suzanne one of thousands of British Columbians who care ... […]
What Will it Take to Prevent Alzheimers? Cheek Swabs to Determine Risk at Ontario Science Centre
on January 17, 2019 at 11:56 am
At Ontario Science Centre, Dr. Sharon Cohen, Toronto Memory Program's medical director, and Cyndy Cordell of Global Alzheimer's Platform, discuss Alzheimer's research, the cheek swab genotype screenin... […]
Western Alzheimers hold a celebration of women
on January 17, 2019 at 9:00 am
Western Alzheimers Association earlier this month held their inaugural Nollaig na mBan Ladies Luncheon at the Lodge at Ashford Castle. The event took a twist on the traditional association of Nollaig ... […]
Sheepdog trials: Alzheimers South Canterbury given $2400 raised at trials
on January 16, 2019 at 10:31 am
Alzheimers South Canterbury has benefited from a highly successful dog trials event held near Pleasant Point late last year. The South Canterbury Tux Yarding Challenge and Winchester Tux Handy Dog Cha... […]
Former Academy of Art star Jasmin Guinn finds herself preparing for Titan Games
on January 16, 2019 at 12:22 am
She was barely sleeping. She would go to class to finish her degree and then work during the day, and stayed up until 5 a.m. to take care of her grandmother, who had recently been diagnosed with Alzhe... […]
Senior Care Center Connects California Families To Top Alzheimers Care Facilities In The State
on January 14, 2019 at 3:49 pm
Senior Care Center, a California based company that focuses on senior care services, highlights the financial benefits of sending aging family members to Alzheimer care facilities. This is especially ... […]
Alzheimer's Association Community Forum
on January 13, 2019 at 4:07 am
Augusta GA (WJBF) - Alzheimers doesn't only affect the patient, but family and friends as well. Beth Williams from the Alzheimer's Association stopped by Television Park and talked with News Channel 6 ... […]
Parkrun addict Karen Penny to walk around coast of Britain and Ireland for Alzheimers Research UK
on January 12, 2019 at 1:17 pm
A 53-YEAR-OLD woman plans to walk 20,000 miles over four years to help a charity close to her heart. Karen Penny, a member of Newport Parkrun and Lliswerry Runners, plans to walk from the Gower around ... […]
Fair queen donates to Lutheran Home, Alzheimers Association
on January 11, 2019 at 1:00 pm
Support quality local journalism. Become a subscriber. Didn't get a chance to finish your story? Purchase a day pass digital subscription and you'll receive unlimited online access for one day (24 hou... […]
via Bing News